18
1
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T7734 |
BETA-CFT sulfate
|
Others | Others |
BETA-CFT sulfate 是BETA-CFT 的衍生物。BETA-CFT 是多巴胺转运蛋白(DATs)的拮抗剂。 | |||
T60024 |
CFT7455
Cemsidomide |
Ligand for E3 Ligase | PROTAC |
CFT7455 (Cemsidomide) 是一种抗癌剂,对 cereblon E3 连接酶具有高亲和力,Kd 为 0.9 nM。 CFT7455 是锌指转录因子 Ikaros (IKZF1) 和 Aiolos (IKZF3) 的口服活性降解剂。 | |||
T22290 |
CFT-743
|
Others | Others |
CFT-0743 could inhibits tumor growth (81% regression) potently with PDC50 value of 0.18 nM. | |||
T82742 |
CFT-2718
|
PROTACs | PROTAC |
CFT-2718为一种新型BRD4靶向降解剂(PROTAC),其催化活性增强,体内特性优良。 | |||
T71741 |
PPK-188
|
Others | Others |
PPK-188, also known as CFT, is a novel selective covalent inhibitor of tryparedoxin (tpx), efficiently killing live african trypansosomes | |||
T73425 |
CFT8634
|
Epigenetic Reader Domain | Chromatin/Epigenetic |
CFT8634 是一种具有口服活性和选择的降解剂,靶向 BRD9,可用于治疗SMARCB1扰动癌症。CFT8634 可诱导与 BRD9 和 E3 连接酶形成三元复合物,诱导 BRD9 泛素化并随后被蛋白酶体降解。 | |||
T77972 |
CFT1946
|
Ligands for Target Protein for PROTAC; PROTACs | PROTAC |
CFT1946 是一种选择性口服 BRAF 激酶抑制剂,专门针对突变型 BRAFV600E、G469A、G466V 及 p61-BRAFV600E 的降解剂。该化合物主要应用于肿瘤相关研究。 | |||
T63024 |
(Rac)-CFT7455
|
Others | Others |
(Rac)-CFT7455 是一种 Ikaros/Aiolos 降解剂,通过泛素蛋白酶体途径发挥作用,能够作用于 NCIH929.1 细胞 (GI50: 0.05 nM)。(Rac)-CFT7455 是 CFT7455 的外消旋异构体,具有抗癌作用。 | |||
T78660 |
(S,R)-CFT8634
|
Epigenetic Reader Domain | Chromatin/Epigenetic |
(S,R)-CFT8634为选择性与口服活性BRD9蛋白降解剂,潜在用途覆盖BRD9介导疾病研究,包含细胞增殖异常等。 | |||
T2355 |
CFTR(inh)-172
CFTRinh 172,CFTR Inhibitor-172,CFTRinh-172,CFTRinh172 |
CFTR; Autophagy | Autophagy; Membrane transporter/Ion channel |
CFTR(inh)-172 (CFTR Inhibitor-172) 是一种不依赖电压的选择性 CFTR 抑制剂,在2分钟内可逆地抑制CFTR 短路电流的Ki 值为300 nM。 | |||
T60653 |
CFTR corrector 9
|
CFTR | Membrane transporter/Ion channel |
CFTR corrector 9是一种囊性纤维化跨膜传导调节蛋白 (CFTR)调节剂。CFTR corrector 9 可用于研究囊性纤维化 (CF) 和其他 CFTR 相关疾病。 | |||
T10776 |
CFTR corrector 4
|
CFTR | Membrane transporter/Ion channel |
CFTR corrector 4是一种高效且可口服的囊性纤维化跨膜电导调节剂 (CFTR),是一种有效的 (R,R) 型活性对映体。CFTR corrector 4 可以增加细胞表面的 CFTR 水平,是用来研究囊性纤维化的潜在化合物。 | |||
T79578 |
CFTR corrector 12
|
CFTR | Membrane transporter/Ion channel |
CFTRcorrector 12(compound 17C)作为一种双噻唑衍生物,本身是CFTR校正剂。它具有校正控制氯离子跨膜运输通道的特定折叠缺陷突变的功能,并能够在带有突变的细胞中恢复α-肌聚糖(α-SG)的含量。 | |||
T5312 |
CFTR corrector 2
FDL169 |
CFTR; Autophagy | Autophagy; Membrane transporter/Ion channel |
CFTR corrector 2 (FDL169) 是一种新型有效的囊性纤维化跨膜电导调节因子(CFTR)调节剂,用于治疗携带 F508del 突变的囊性纤维化患者。 | |||
T63806 |
CFTR corrector 8
|
CFTR | Membrane transporter/Ion channel |
CFTR corrector 8 is a highly effective modulator of the cystic fibrosis transmembrane conductance regulator (CFTR). This compound is specifically designed for utilization in research related to cystic fibrosis, a genetic disorder primarily affecting the lungs and digestive system [1]. | |||
T37686 |
CFTR corrector 6
|
Others | Others |
CFTR corrector 6 is a highly effective CFTR potentiator utilized in research on cystic fibrosis (CF) and related CFTR-associated disorders[1]. This potent compound exhibits potentiation activity on the Cystic Fibrosis Transmembrane conductance Regulator (CFTR), rendering it beneficial for investigations in CF and other associated conditions. | |||
T39628 |
PROTAC BRD4 ligand-2
PROTAC BRD4 ligand-2 |
Others | Others |
PROTAC BRD4 ligand-2 is a ligand for target BRD4 protein for PROTAC CFT-2718. | |||
T77921 |
PROTAC BRD4 ligand-2 hydrochloride
|
Ligands for Target Protein for PROTAC | PROTAC |
PROTACBRD4配体-2盐酸盐是一种专门针对BRD4蛋白的配体,主要用于PROTACCFT-2718的合成过程中。 |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPH-00387 |
Toxin CfTX-1 Protein, Chironex fleckeri, Recombinant (His & SUMO)
Toxin CfTX-1 |
Chironex fleckeri | E. coli |
Toxin CfTX-1 Protein, Chironex fleckeri, Recombinant (His & SUMO) is expressed in E. coli expression system with N-6xHis-SUMO tag. The predicted molecular weight is 65.1 kDa and the accession number is A7L035. |